The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigenMiladys Limonta‐Fernández, Gerardo Guillén, Eulogio Pimentel-Vázquez et al.|medRxiv|2021Cited by 19
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|Analytical and Bioanalytical Chemistry|2021Cited by 17
Immunogenicity of recombinant class 1 protein from Neisseria meningitidis refolded into phospholipid vesicles and detergentOlivia Niebla, Gerardo Guillén, Anabel Álvarez et al.|Vaccine|2001Cited by 13
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader FunctionalityYadira Lobaina, Lisset Hermida, Rong Chen et al.|Viruses|2024Cited by 11
Association of the P64k dihydrolipoamide dehydrogenase to the Neisseria meningitidis membraneAnabel Álvarez, Ricardo Silva, A.M. Martin et al.|Biotecnología aplicada|2004Cited by 5